Antiviral prophylaxis for varicella zoster virus infections in patients with myeloma in the era of novel therapies

Varicella zoster virus reactivation after autologous SCT is a frequent event and associated with favorable outcome in myeloma patients

(2015) C Kamber et al.   BONE MARROW TRANSPLANTATION

Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy

(2015) Benjamin W. Teh et al.   BRITISH JOURNAL OF HAEMATOLOGY

Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization

(2015) Benjamin W Teh et al.   Expert Review of Anti-Infective Therapy

Changing treatment paradigms for patients with plasma cell myeloma: Impact upon immune determinants of infection

(2014) Benjamin W. Teh et al.   BLOOD REVIEWS

Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients

(2014) C. Blimark et al.   HAEMATOLOGICA

Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital

(2014) Benjamin W. Teh et al.   SUPPORTIVE CARE IN CANCER

Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients

(2013) C. König et al.   ANNALS OF HEMATOLOGY

Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipients

(2013) Quoc Truong et al.   ANNALS OF HEMATOLOGY

Lenalidomide consolidation and maintenance therapy after autologous stem cell transplant for multiple myeloma induces persistent changes in T-cell homeostasis

(2013) Emmanuel Clave et al.   LEUKEMIA & LYMPHOMA

Analysis of Herpes Zoster Events Among Bortezomib-Treated Patients in the Phase III APEX Study

(2008) Asher Chanan-Khan et al.   JOURNAL OF CLINICAL ONCOLOGY